Please assess the completion status of the following clinical trial:

Trial Title: Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Recipient of a primary liver graft~* Absence of any of our exclusion criteria~Exclusion Criteria:~* Pretransplant renal failure, defined as serum creatinine \> 1.5 mg/dL~* Severe pretransplant thrombopenia, defined as platelets \< 50000/mL~* Combined liver-kidney transplantation~* Autoimmune hepatitis, primary biliary cirrhosis or primary sclerosing cholangitis as causes of liver transplantation~* Chronic hepatic encephalopathy~* Living donor liver transplantation~* Recipient with human immunodeficiency virus infection~* Severe pretransplant leukopenia, defined as \< 1500 leukocytes/mL

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).